Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab versus neoadjuvant chemotherapy plus tislelizumab for locally advanced esophageal squamous cell cancer: a real-world retrospective study

Perioperative outcomes of neoadjuvant chemotherapy plus camrelizumab versus neoadjuvant chemotherapy plus tislelizumab for locally advanced esophageal squamous cell cancer: a real-world retrospective study

BackgroundWhile neoadjuvant chemoimmunotherapy shows promise for locally advanced esophageal squamous cell carcinoma (ESCC), optimal regimen selection remains challenging. This study compares perioperative outcomes between camrelizumab- and tislelizumab-based neoadjuvant chemoimmunotherapy in ESCC.M...

Full description

Saved in:
Bibliographic Details
Main Authors: Qi Zhao, Yusen Yuan, Tongxin Xu, Ningning Yan, Fei Li, Juntao Lu, Ming He, Zhaoyang Yan
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Immunology
Subjects:
esophageal squamous cell carcinoma
neoadjuvant therapy
tislelizumab
camrelizumab
immunotherapy
esophagectomy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1544739/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1544739/full

Similar Items